Humphrey Jeffrey insider trades
Humphrey Jeffrey has filed 9 Form 4s with the SEC that we hold, for Dianthus Therapeutics, Inc. /DE/ (MGTA) (Chief Medical Officer), CYT (Director), CNST (Chief Medical Officer) and Lantheus Holdings, Inc. (LNTH) (Chief Medical Officer). None of these filings reports a purchase (code P) or sale (code S) of common stock; they cover grants, option exercises and other codes. The first filing on our record is dated 2021-07-19 and the latest 2024-06-20.
Dianthus Therapeutics, Inc. /DE/ (MGTA)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
CYT
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
CNST
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Lantheus Holdings, Inc. (LNTH)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1816944) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms